Completed Studies

The Ponce CRS has successfully completed recruitment in a number of treatment and prevention studies related to HIV, TB, and COVID. See below for some of these studies.

Please note - the following studies are no longer enrolling participants

The Ponce CRS has completed numerous NIH-funded AIDS Clinical Trials Group (ACTG) studies, with more than 500 participants.

 A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), for Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men.

The mRNA-1273 vaccine was developed to prevent COVID-19. The purpose of this study was to test Moderna’s vaccine candidate to see if it can prevent illness if people are exposed to the SARS-CoV-2 virus in their everyday lives.